What is the purpose of the study?
The purpose is to detect pancreatic cancer at its earliest stages by using magnetic resonance imaging (MRI) and blood tests. Individuals diagnosed with new-onset diabetes (NOD) and who are over 50 years of age have an approximate eight-fold higher risk of developing pancreatic cancer within two years of a diabetes diagnosis. It is estimated that approximately 1% of individuals with NOD develop pancreatic cancer within two years of their diabetes diagnosis. The goal of the study is to determine which individuals with new-onset diabetes are at risk.
Are you eligible to participate?
- Are you at least 50 years of age?
- Have you been diagnosed with diabetes within the past 12 months?
- Are you able to undergo an MRI?
What is the study plan?
If enrolled in the trial, you will undergo a baseline magnetic resonance imaging (MRI) scan of the pancreas. Research staff will also evaluate your overall health every 6 months and obtain a blood sample for research purposes. Before participation, risks and benefits will be explained in detail during a process called informed consent.
Who will pay for the MRI tests and other study procedures?
Nuvance Health will cover the costs of MRI examinations AND other study related costs through philanthropic donations.
Is this study being performed at other centers?
Not at this time.
Who is leading the study?
The principal investigator of the study is Richard Frank, MD
, director of cancer research at Nuvance Health.
For more information, or if you would like to see if you
qualify, please contact Tammy Lo, APRN at (203)855-3551 or email@example.com.